Prior to being appointed to this senior leadership position at the FDA, Anna served as the long-time health policy director and senior advisor to Sen. Richard Burr (R-NC) for all health care issues, including health care policy under the jurisdiction of the Senate Finance Committee and Senate Health, Education, Labor, and Pensions (HELP) Committee. Anna’s contributions to advancing bipartisan FDA and medical and public health preparedness and response legislation were notable during her tenure with the Senate HELP Committee, including securing multiple patient-centered drug and device provisions in the Food and Drug Administration Safety and Innovation Act and 21st Century Cures Act.